Zahir Lavji
Directeur/Membre du Conseil chez Temple Therapeutics BV
Profil
Zahir Lavji is currently a Director at Temple Therapeutics BV.
Previously, he worked as a Vice President-Japan Operations at Abbott Laboratories.
Postes actifs de Zahir Lavji
| Sociétés | Poste | Début |
|---|---|---|
Temple Therapeutics BV
 Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | Directeur/Membre du Conseil | - |
Anciens postes connus de Zahir Lavji
| Sociétés | Poste | Fin |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | 18/11/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 1 |
|---|---|
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | Health Technology |